scholarly article | Q13442814 |
P2093 | author name string | Dieter Kunz | |
Richard Mahlberg | |||
P2860 | cites work | Polysomnographic features of REM sleep behavior disorder: Development of a scoring method | Q34456586 |
REM sleep behavior disorders in multiple system atrophy | Q34739276 | ||
REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease | Q34750968 | ||
Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder | Q49153394 | ||
P433 | issue | 4 | |
P921 | main subject | melatonin | Q180912 |
placebo | Q269829 | ||
placebo-controlled trial | Q108853737 | ||
P304 | page(s) | 591-596 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | Journal of Sleep Research | Q15762584 |
P1476 | title | A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder | |
P478 | volume | 19 |
Q98177555 | A Neurologist's Guide to REM Sleep Behavior Disorder |
Q92753479 | A Stage-Based Approach to Therapy in Parkinson's Disease |
Q35583079 | A novel therapy for REM sleep behavior disorder (RBD). |
Q48334700 | A sleep-centric view |
Q41492642 | An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder |
Q33744393 | Case Report of Rapid-eye-movement (REM) sleep behavior disorder |
Q57446285 | Circadian Dysfunction in Parkinson's Disease |
Q28384426 | Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model |
Q48642615 | Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia |
Q92140254 | Comorbid Depression Is Associated with a Negative Treatment Response in Idiopathic REM Sleep Behavior Disorder |
Q35703007 | Dementia with lewy bodies: diagnosis and management for primary care providers |
Q35849869 | Diagnostic delay in REM sleep behavior disorder (RBD) |
Q53406124 | Disturbances of Sleep and Alertness in Parkinson's Disease. |
Q35740613 | Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials |
Q38233015 | Headache, drugs and sleep |
Q39510729 | Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. |
Q38772198 | Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions |
Q48303563 | Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. |
Q38725005 | Investigation effect of oral chamomilla on sleep quality in elderly people in Isfahan: A randomized control trial |
Q38693579 | Lifestyle Factors and Migraine in Childhood |
Q39100264 | Management of sleep disorders in Parkinson's disease and multiple system atrophy |
Q38834700 | Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases. |
Q26825314 | Melatonin therapy for REM sleep behavior disorder: a critical review of evidence |
Q92404286 | Melatonin: Clinical Perspectives in Neurodegeneration |
Q34730974 | Meta-analysis: melatonin for the treatment of primary sleep disorders |
Q92000682 | Neuromodulation of the Pineal Gland via Electrical Stimulation of Its Sympathetic Innervation Pathway |
Q26749275 | Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development |
Q38107409 | Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. |
Q91744494 | New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease |
Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
Q30526455 | Parasomnias: an updated review |
Q92521613 | Pineal gland volume is associated with prevalent and incident isolated rapid eye movement sleep behavior disorder |
Q64119035 | Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder |
Q47911217 | Prospective Study on Salivary Evening Melatonin and Sleep before and after Pinealectomy in Humans |
Q38206498 | Psychiatric issues in cognitive impairment |
Q39312598 | REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies |
Q47666202 | REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions |
Q36851239 | REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease |
Q38198523 | REM sleep behavior disorder in Parkinson's disease |
Q37996946 | REM sleep behavior disorder: motor manifestations and pathophysiology |
Q45931015 | Ramelteon for Idiopathic REM Sleep Behavior Disorder: Implications for Pathophysiology and Future Treatment Trials. |
Q91646654 | Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: An Update |
Q58563261 | Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update |
Q47659714 | SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE. |
Q57767367 | Scoring atonia during normal and pathological rapid eye movement sleep: Visual and automatic quantification methods |
Q38838762 | Seeking Good Alternatives to Clonazepam: Suggestions for Future Treatment Trials in REM Sleep Behavior Disorder |
Q38222443 | Sleep Disorders in Atypical Parkinsonism |
Q38807628 | Sleep Disturbances in the Prodromal Stage of Parkinson Disease |
Q36725295 | Sleep and non-motor symptoms in Parkinson's disease |
Q48228995 | Sleep and violence |
Q48228322 | Sleep dysfunction in multiple system atrophy |
Q88990610 | Therapeutic Symptomatic Strategies in the Parasomnias |
Q38810158 | Treatment of REM Sleep Behavior Disorder |
Q39342961 | Treatment of Sleep Dysfunction in Parkinson's Disease. |
Q48221262 | Treatment of dyssomnias and parasomnias in childhood |
Q38165855 | Treatment of the sleep disorders associated with Parkinson's disease |
Q48290983 | Treatment options for sleep dysfunction in Parkinson's disease. |
Q34324499 | Treatment outcomes in REM sleep behavior disorder. |
Q35252023 | When is it dementia? |
Q87050948 | [REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy] |
Search more.